Zigapusnik (Talk | contribs) |
|||
(4 intermediate revisions by 2 users not shown) | |||
Line 89: | Line 89: | ||
<li>Four new active split site-specific proteases were designed in addition to the previously published TEVp. | <li>Four new active split site-specific proteases were designed in addition to the previously published TEVp. | ||
<li>The new split proteases were shown to rapidly respond to regulated by induced chemical dimerization. | <li>The new split proteases were shown to rapidly respond to regulated by induced chemical dimerization. | ||
+ | <li>We demonstrated higher cleavage activity of the TEVp homologues against | ||
+ | their respective substrates in comparison to the already existing split | ||
+ | TEVp. | ||
</ul></b></p> | </ul></b></p> | ||
</div> | </div> | ||
Line 105: | Line 108: | ||
<img src="https://static.igem.org/mediawiki/2016/0/00/T--Slovenia--4.4.5.png"> | <img src="https://static.igem.org/mediawiki/2016/0/00/T--Slovenia--4.4.5.png"> | ||
<figcaption><b>Reconstituted split-TEVp</b><br/> | <figcaption><b>Reconstituted split-TEVp</b><br/> | ||
− | <p style="text-align:justify">Model of nTEVp (residues 1 – 118 in blue) and cTEVp (residues 119 – 242 in orange) reconstituted in the active form | + | <p style="text-align:justify">Model of nTEVp (residues 1 – 118 in blue) and cTEVp (residues 119 – 242 in orange) reconstituted in the active form |
(from PDB 1LVB). | (from PDB 1LVB). | ||
</p> | </p> | ||
Line 115: | Line 118: | ||
<p>Our team hypothesized that the same inducible dimerization approach could also be used with TEVp homologues. We converted all of the tested orthogonal potyviral proteases | <p>Our team hypothesized that the same inducible dimerization approach could also be used with TEVp homologues. We converted all of the tested orthogonal potyviral proteases | ||
to split proteases by splitting them at positions corresponding to the position of the previously described split TEV protease. We selected three different types of | to split proteases by splitting them at positions corresponding to the position of the previously described split TEV protease. We selected three different types of | ||
− | dimerization domains to induce the activity of the split proteases. The first pair of dimerization domains was the rapamycin responsive FKBP/FRB system <x-ref> Banaszynski | + | dimerization domains to induce the activity of the split proteases. The first pair of dimerization domains was the rapamycin responsive FKBP/FRB system <x-ref>Banaszynski</x-ref>, which induces dimerization upon ligand binding. The second pair of dimerization domains was the |
− | + | ||
<a href="https://2016.igem.org/Team:Slovenia/Protease_signaling/Light_dependent_mediator#cry">CRY2PHR/CIBN system</a>, which induces dimerization upon irradiation with blue light. | <a href="https://2016.igem.org/Team:Slovenia/Protease_signaling/Light_dependent_mediator#cry">CRY2PHR/CIBN system</a>, which induces dimerization upon irradiation with blue light. | ||
Finally, our third system for dimerization was designed to respond to a Ca<sup>2+</sup> influx based on the | Finally, our third system for dimerization was designed to respond to a Ca<sup>2+</sup> influx based on the | ||
Line 132: | Line 134: | ||
<figure data-ref="4.10.1"> | <figure data-ref="4.10.1"> | ||
<img src="https://static.igem.org/mediawiki/2016/d/dd/T--Slovenia--4.10.1.png"> | <img src="https://static.igem.org/mediawiki/2016/d/dd/T--Slovenia--4.10.1.png"> | ||
− | <figcaption><b>Rapamycin and its | + | <figcaption><b>Rapamycin and its mechanism of action.</b><p style="text-align:justify">(A) Chemical structure of rapamycin. Binding sites for FRB and FKBP are shown. (B) Schematic presentation of FKBP and FRB binding to |
rapamycin<x-ref>Banaszynski</x-ref> | rapamycin<x-ref>Banaszynski</x-ref> | ||
</p> | </p> | ||
Line 140: | Line 142: | ||
<p>Interactions among different proteins play a key role among all living organisms. Chemically induced dimerization (CID) is one of such interactions, | <p>Interactions among different proteins play a key role among all living organisms. Chemically induced dimerization (CID) is one of such interactions, | ||
which allows two different protein domains to dimerize after the addition of a small molecule. The most widely used CID to date is the FKBP/FRB system | which allows two different protein domains to dimerize after the addition of a small molecule. The most widely used CID to date is the FKBP/FRB system | ||
− | which heterodimerizes upon rapamycin addition <x-ref> Inobe2016 </x-ref>. | + | which heterodimerizes upon rapamycin addition <x-ref>Inobe2016</x-ref>. |
</p> | </p> | ||
<p>Rapamycin is a 31-membered macrolide antifungal antibiotic that was first isolated from the Streptomyces hygroscopicus and binds with high affinity to the | <p>Rapamycin is a 31-membered macrolide antifungal antibiotic that was first isolated from the Streptomyces hygroscopicus and binds with high affinity to the | ||
Line 193: | Line 195: | ||
</div> | </div> | ||
</div> | </div> | ||
− | < | + | <h3 class="ui left dividing header"><span id="ref-title" class="section colorize"> </span>References |
− | </ | + | </h3> |
<div class="ui segment citing" id="references"></div> | <div class="ui segment citing" id="references"></div> | ||
</div> | </div> |
Latest revision as of 14:13, 19 October 2016
Split orthogonal proteases
The split protein system based on the inducible dimerization is an attractive method to regulate the protease activity. Wehr et al.
Our team hypothesized that the same inducible dimerization approach could also be used with TEVp homologues. We converted all of the tested orthogonal potyviral proteases
to split proteases by splitting them at positions corresponding to the position of the previously described split TEV protease. We selected three different types of
dimerization domains to induce the activity of the split proteases. The first pair of dimerization domains was the rapamycin responsive FKBP/FRB system
Interactions among different proteins play a key role among all living organisms. Chemically induced dimerization (CID) is one of such interactions,
which allows two different protein domains to dimerize after the addition of a small molecule. The most widely used CID to date is the FKBP/FRB system
which heterodimerizes upon rapamycin addition
Rapamycin is a 31-membered macrolide antifungal antibiotic that was first isolated from the Streptomyces hygroscopicus and binds with high affinity to the
12-kDa FK506 binding protein (FKBP) as well as to a 100-aminoacid domain (E2015 to Q2114) of the mammalian target of rapamycin (mTOR) protein known as the
FKBP-rapamycin binding domain (FRB) (4.10.1)
Results
We tested the full set of four orthogonal proteases with the rapamycin inducible system by measuring their activity with the cycLuc reporter. Increasing luciferase activity was detected correlating with the amount of the transfected protease fragments in stimulated cells (4.10.2.). Luciferase in unstimulated cells remained inactive even at the highest amount of transfected protease fragments, proving low leakage and high inducibility of the split protease system in response to rapamycin.
Additionally, we tested the kinetics of rapamycin induction with PPVp and its corresponding cycLuc reporter. We showed that luciferase activity starts increasing just a few minutes after the addition of rapamycin, resulting in activity comparable to activity of the reporter in the presence of constitutively active whole protease within one hour after the induction (4.10.3.).
After demonstrating that the new proteases are active as split enzymes with rapamycin-induced complementation, we adapted the same split system to other inputs. To connect the split protease-based signaling to mechanosensing, we prepared Ca2+ inducible proteases based on calmodulin and M13 interaction. The first results look promising; however we have to confirm them in the repeated experiments. As an additional type of input we prepared light inducible split proteases.